ClinicalTrials.govpublic full text
Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia
acute leukemia, relapse, hematopoietic stem cell transplantation, sorafenib, flt3-negative, allogeneic hematopoietic stem cell transplantation, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 851154
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.